Vast Majority in US Remain Susceptible to COVID-19: Study
Vast Majority in US Remain Susceptible to COVID-19: Study
Fewer than 1 in 10 dialysis patients sampled had antibodies against the novel coronavirus as of July, indicating that the greater population is far from levels required to achieve herd immunity.
Vast Majority in US Remain Susceptible to COVID-19: Study
Vast Majority in US Remain Susceptible to COVID-19: Study

Fewer than 1 in 10 dialysis patients sampled had antibodies against the novel coronavirus as of July, indicating that the greater population is far from levels required to achieve herd immunity.

Fewer than 1 in 10 dialysis patients sampled had antibodies against the novel coronavirus as of July, indicating that the greater population is far from levels required to achieve herd immunity.

The Lancet
<em>The Lancet&nbsp;</em>Alters Editorial Practices After Surgisphere Scandal
The Lancet Alters Editorial Practices After Surgisphere Scandal
Catherine Offord | Sep 22, 2020
The changes, which affect the declarations authors have to sign and the peer-review process, have received a mixed response from the scientific community.
Scientists Voice Concerns over Russian COVID-19 Vaccine Study
Scientists Voice Concerns over Russian COVID-19 Vaccine Study
Amanda Heidt | Sep 11, 2020
Almost 40 scientists have signed an open letter, citing odd patterns in the data and a lack of transparency after authors withheld the full data.
<em>Lancet, NEJM </em>Retract Surgisphere Studies on COVID-19 Patients
Lancet, NEJM Retract Surgisphere Studies on COVID-19 Patients
Catherine Offord | Jun 4, 2020
All authors other than company founder and CEO Sapan Desai were “unable to complete an independent audit of the data,” The Lancet states.
Concerns Build Over Surgisphere&rsquo;s COVID-19 Dataset
Concerns Build Over Surgisphere’s COVID-19 Dataset
Catherine Offord | Jun 2, 2020
NEJM and The Lancet issue expressions of concern as researchers question where the company got its data on thousands of coronavirus patients.
Exclusive
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere
Catherine Offord | May 30, 2020
Scientists have raised questions about the dataset published in The Lancet last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study.
<em>The Lancet</em> Retracts Cardiac Stem Cell Clinical Trial Paper
The Lancet Retracts Cardiac Stem Cell Clinical Trial Paper
Kerry Grens | Mar 14, 2019
The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.
Open-Access Plan in Europe Bans Publishing in Paywalled Journals
Open-Access Plan in Europe Bans Publishing in Paywalled Journals
Ashley Yeager | Sep 4, 2018
Research funding agencies in Europe will require grantees’ papers to be free to read when they are available online.
Longer Lives, More Disease
Longer Lives, More Disease
Dan Cossins | Dec 14, 2012
A comprehensive global health study finds that although life expectancy has increased in most countries, the burden of chronic disease is also on the rise.
Trouble at the CDC?
Bob Grant | Mar 12, 2012
Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.